Trial approval for PYC Therapeutics

15/08/2024 - 14:59

Bookmark

Upgrade your subscription to use this feature.

Perth biotech company PYC Therapeutics has hit another major milestone, gaining approval to move its first-in-class PYC-001 drug to human trials.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options